<DOC>
	<DOCNO>NCT01298037</DOCNO>
	<brief_summary>This ancillary NIDDK-sponsored Hepatitis B Research Network ( HBRN ) Study Cohort Study NCT01263587 . This study examine balance immune regulatory effector response hepatitis B-infected participant enrol HBRN study ( NCT01263587 ) .</brief_summary>
	<brief_title>HBRN : Immune Regulation Costimulation Natural History Chronic Hepatitis B</brief_title>
	<detailed_description>Aim 1 : The clinical virological status chronic Hepatitis B ( HBV ) infection define distinct pattern immune effector regulatory response : The investigator propose one immune regulatory induce chronic hepatitis B define extent immune tolerance vs. activation associate disease activity viremia . Towards end , immune effector regulatory response relative serum HBV DNA , alanine aminotransferase ( ALT ) , Hepatitis B e antigen ( HBeAg ) , Hepatitis B surface antigen ( HBsAg ) liver histology examine cross-sectional manner patient chronic HBV control group . Aim 2 : Clinical hepatitis flare chronic hepatitis B reflect alter balance immune regulatory effector response .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>â€¢ Providing informed consent ancillary study . Children 18 year age , participant anemia Hgb &lt; 10 Hct &lt; 30 , congestive heart failure chronic lung disease require oxygen , active coronary artery disease unstable angina , sepsis renal failure , significant medical condition , autoimmune disease immunosuppression .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Immunology , Hepatitis B , HBV</keyword>
</DOC>